GB1549524A - Composition for the treatment of cancer - Google Patents

Composition for the treatment of cancer

Info

Publication number
GB1549524A
GB1549524A GB1816/77A GB181677A GB1549524A GB 1549524 A GB1549524 A GB 1549524A GB 1816/77 A GB1816/77 A GB 1816/77A GB 181677 A GB181677 A GB 181677A GB 1549524 A GB1549524 A GB 1549524A
Authority
GB
United Kingdom
Prior art keywords
cancer
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1816/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB1816/77A priority Critical patent/GB1549524A/en
Priority to DE2801355A priority patent/DE2801355C2/de
Priority to DK23478A priority patent/DK158226C/da
Priority to JP53002839A priority patent/JPS6045638B2/ja
Priority to FR7801246A priority patent/FR2377393A1/fr
Publication of GB1549524A publication Critical patent/GB1549524A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
GB1816/77A 1977-01-17 1977-01-17 Composition for the treatment of cancer Expired GB1549524A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB1816/77A GB1549524A (en) 1977-01-17 1977-01-17 Composition for the treatment of cancer
DE2801355A DE2801355C2 (de) 1977-01-17 1978-01-13 Komplexverbindung aus Ascorbinsäure, dreiwertigem Titan und zweiwertigem Kupfer
DK23478A DK158226C (da) 1977-01-17 1978-01-17 Analogifremgangsmaade til fremstilling af en kompleks forbindelse af ascorbinsyre, trivalent titan og divalent kobber
JP53002839A JPS6045638B2 (ja) 1977-01-17 1978-01-17 錯化合物およびその製造方法
FR7801246A FR2377393A1 (fr) 1977-01-17 1978-01-17 Nouveau complexe de titane trivalent et de cuivre divalent de l'acide ascorbique utile notamment pour le traitement des maladies comportant des anomalies de formule sanguine, et son procede de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1816/77A GB1549524A (en) 1977-01-17 1977-01-17 Composition for the treatment of cancer

Publications (1)

Publication Number Publication Date
GB1549524A true GB1549524A (en) 1979-08-08

Family

ID=9728526

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1816/77A Expired GB1549524A (en) 1977-01-17 1977-01-17 Composition for the treatment of cancer

Country Status (4)

Country Link
JP (1) JPS6045638B2 (da)
DE (1) DE2801355C2 (da)
FR (1) FR2377393A1 (da)
GB (1) GB1549524A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0046409A1 (en) * 1980-08-20 1982-02-24 Erwin Günther Walliczek A process for the preparation of a solution of a cuprous complex; solutions of the cuprous complexes for use in the therapeutic treatment of the human or animal body; and a method of therapeutic treatment of a plant
IL63928A (en) * 1980-10-04 1985-02-28 Byk Gulden Lomberg Chem Fab Pharmaceutical compositions comprising beta-diketone metal complexes,some such novel complexes and their preparation
HU183536B (en) * 1981-08-04 1984-05-28 Nitrokemia Ipartelepek Process for preparing feed additive or feed promoting the weight increase of domestic animals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR807877A (fr) * 1935-10-10 1937-01-23 Préparation et isolement de sels complexes de l'acide ascorbique et de ses produits d'oxydation
FR805335A (fr) * 1935-10-10 1936-11-17 Préparation et isolement des composés de l'acide ascorbique et de ses produits d'oxydation avec les métaux susceptibles de donner des sels complexes

Also Published As

Publication number Publication date
JPS53111056A (en) 1978-09-28
JPS6045638B2 (ja) 1985-10-11
FR2377393B1 (da) 1981-07-31
DE2801355C2 (de) 1986-11-06
FR2377393A1 (fr) 1978-08-11
DE2801355A1 (de) 1978-07-20

Similar Documents

Publication Publication Date Title
JPS53139734A (en) Keratin treating composition
AU528334B2 (en) Scalp treatment composition
JPS5446842A (en) Skin treating composition
ZA782568B (en) Treatment of slurries
GB2003057B (en) Treatment of iron
JPS542341A (en) Medical composition
ZA782125B (en) Composition for the treatment of hyperpigmentary dermatoses
JPS5215826A (en) Medical composition
JPS5428829A (en) Antiithrombosis medical composition
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
JPS55120514A (en) Composition for local treatment
ZA786299B (en) Process for the preparation of 3-iodo-and bromorifamycin s
JPS53121939A (en) Novel treating composition
ZA786259B (en) Therapeutic composition
GB2015601B (en) Treatment of timber
AU1052676A (en) Tissue treatment
ZA78870B (en) Heterocyclopyrimidines compositions and therapeutic process
GB1549524A (en) Composition for the treatment of cancer
GB2003206B (en) Treatment of timber
DE2860033D1 (en) Medicament for the treatment of depressions
JPS5470432A (en) Medical composition
JPS5413465A (en) Twoostage treatment for effluent
JPS5482337A (en) Treatment such as anodizing
JPS5416489A (en) Antidyeing treatment
JPS542335A (en) Medical composition

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19980109